Workflow
TY PHAR.(002728)
icon
Search documents
利好!多股预增超10倍!
证券时报· 2025-07-14 14:52
Core Viewpoint - The first half of 2025 financial reports from A-share listed companies reveal significant profit increases, with several companies projecting profit growth exceeding tenfold compared to the previous year [1][5]. Group 1: Company Performance - Zhongyan Chemical's 2025 half-year report shows a revenue of 5.998 billion yuan, a decrease of 5.76% year-on-year, with a net profit of 52.7155 million yuan, down 88.04% year-on-year [3][4]. - The decline in Zhongyan Chemical's revenue is attributed to intensified market competition and significant price drops in key products like soda ash and PVC, despite a 38.82% increase in sales volume [3][4]. - Huahong Technology expects a net profit of 70 million to 85 million yuan for the first half of 2025, representing a year-on-year increase of 3047.48% to 3721.94%, driven by improved prices of rare earth raw materials [6][7]. - Wannianqing anticipates a net profit of 31 million to 45 million yuan, reflecting a year-on-year growth of 1954.07% to 2881.71%, supported by recovering demand in the cement industry and cost reduction efforts [6][7]. - Other companies like Yatai Pharmaceutical and Aerospace Science and Technology also project substantial profit increases, with expected growth rates of 1726.42% to 1909.06% and 1628.83% to 2315.27%, respectively [7]. Group 2: Market Trends - The overall trend indicates a recovery in certain sectors, such as the cement industry, due to reduced declines in real estate investment and infrastructure spending [7]. - The chemical industry is experiencing price fluctuations, with some products seeing significant price drops due to weakened downstream demand, while others like caustic soda have increased prices due to demand pull [4].
晚间公告丨7月14日这些公告有看头
第一财经· 2025-07-14 14:30
Major Events - Zhonghua Equipment plans to acquire 100% equity of Yiyang Rubber and Plastic Machinery Group and Beihua Machinery, with stock suspension starting July 15, 2025 [3] - Suzhou Planning intends to purchase 100% equity of Dongjin Aerospace through a combination of cash and stock issuance, with stock resuming trading on July 15, 2025 [4] - Aerospace Development's independent director was detained for personal reasons unrelated to the company's operations, which remain stable [5][6] - *ST Tianmao issued a risk warning regarding potential delisting due to failure to disclose annual reports in time [7] - ST Shuntian will suspend trading for one day on July 15, 2025, and will remove other risk warnings, changing its stock name to Jiangsu Shuntian [8] - Xinghui Entertainment plans to transfer 99.66% equity of Espanyol Football Club for €130 million, focusing on core business areas [9] Performance Reports - China Salt Chemical reported a 5.76% decrease in revenue to ¥5.998 billion and an 88.04% drop in net profit to ¥52.71 million for the first half of 2025 [10] - Jiu Gui Jiu expects a net profit of ¥8 million to ¥12 million, down 90.08% to 93.39% year-on-year, with revenue around ¥560 million, a 43% decline [11] - Suli Co. anticipates a net profit of ¥72 million to ¥86 million, up 1008.39% to 1223.91% year-on-year, driven by increased sales and prices [12] - Te Yi Pharmaceutical expects a net profit of ¥34 million to ¥38 million, a growth of 1164.22% to 1312.95% year-on-year, due to strong sales of its core product [13] - Huahong Technology forecasts a net profit of ¥70 million to ¥85 million, up 3047.48% to 3721.94% year-on-year, benefiting from improved market conditions [14] - Qianfang Technology expects a net profit of ¥150 million to ¥200 million, an increase of 1125.99% to 1534.65% year-on-year, influenced by fair value changes of equity instruments [15] - Huaxia Airlines anticipates a net profit of ¥220 million to ¥290 million, up 741.26% to 1008.93% year-on-year, due to improved flight demand [16] - Xianfeng Holdings expects a net profit of ¥34 million to ¥42 million, a growth of 524.58% to 671.53% year-on-year, mainly from non-recurring gains [17] - Xinyi Sheng expects a net profit of ¥370 million to ¥420 million, up 327.68% to 385.47% year-on-year, driven by AI-related investments [18] - Haili Co. anticipates a net profit of ¥30.5 million to ¥36 million, a growth of 625.83% to 756.71% year-on-year, due to improved sales [19] - Hengsheng Electronics expects a net profit of approximately ¥251 million, an increase of about 740.95% year-on-year, due to significant non-recurring gains [20] - Tianqi Lithium expects a net profit of ¥0 to ¥155 million, recovering from a loss of ¥5.206 billion in the previous year [21] - Shui Jing Fang forecasts revenue of ¥1.498 billion, down 12.84%, and a net profit of ¥105 million, down 56.52% [22] - CICC expects a net profit of ¥3.453 billion to ¥3.966 billion, an increase of 55% to 78% year-on-year [23] - Shenwan Hongyuan anticipates a net profit of ¥4.1 billion to ¥4.5 billion, a growth of 92.66% to 111.46% year-on-year [24] - Xinda Securities expects a net profit of ¥921 million to ¥1.044 billion, an increase of 50% to 70% year-on-year [25] - Shanxi Securities anticipates a net profit of ¥504 million to ¥544 million, a growth of 58.17% to 70.72% year-on-year [26] - Guohai Securities expects a net profit of ¥370 million, a growth of 159.26% year-on-year [27] - Guocheng Mining anticipates a net profit of ¥493 million to ¥548 million, a growth of 1046.75% to 1174.69% year-on-year [28] - China Rare Earth expects a net profit of ¥136 million to ¥176 million, recovering from a loss of ¥244 million [29] - Perfect World anticipates a net profit of ¥480 million to ¥520 million, recovering from a loss of ¥177 million [30] - Fangda Carbon expects a net profit of ¥50 million to ¥60 million, down 65.13% to 70.93% year-on-year [31] - Huanghe Xuanfeng expects a net loss of ¥285 million [32] - JA Solar anticipates a net loss of ¥2.5 billion to ¥3 billion, worsening from a loss of ¥874 million [33] - Shanxi Black Cat expects a net loss of ¥490 million to ¥540 million [34] - Ganfeng Lithium anticipates a net loss of ¥300 million to ¥550 million, improving from a loss of ¥760 million [35] - Xinda Real Estate expects a net loss of ¥3.5 billion to ¥3.9 billion [36] - Greenland Holdings anticipates a net loss of ¥3 billion to ¥3.5 billion [37] - Air China expects a net loss of ¥1.7 billion to ¥2.2 billion [39] - OFILM expects a net loss of ¥85 million to ¥115 million [40] - Vanke A expects a net loss of ¥10 billion to ¥12 billion [41] Major Contracts - Zhongchen Co. won a project from Southern Power Grid worth ¥379 million, accounting for 12.26% of its 2024 audited revenue [42] - Gaode Infrared signed a procurement agreement worth ¥879 million, representing 32.84% of its 2024 audited revenue [43]
晚间公告丨7月14日这些公告有看头
Di Yi Cai Jing· 2025-07-14 10:41
Core Viewpoint - Multiple listed companies in the Shanghai and Shenzhen markets have announced significant changes in their financial forecasts and strategic decisions, indicating varied performance across different sectors in the first half of 2025 [1][3]. Company Announcements - Zhonghua Equipment plans to acquire 100% stakes in Yiyang Rubber and Plastic Machinery Group and Beihua Machinery, with stock suspension starting July 15, 2025, for up to 10 trading days [3]. - Jiugui Liquor expects a net profit decline of 90.08% to 93.39% in the first half of 2025, with projected revenue around 560 million yuan, a decrease of approximately 43% year-on-year [5]. - Suli Co. anticipates a net profit increase of 1008.39% to 1223.91%, with expected profits between 72 million and 86 million yuan, driven by improved market conditions [6]. - Te Yi Pharmaceutical forecasts a net profit growth of 1164.22% to 1312.95%, with profits expected between 34 million and 38 million yuan, supported by strong sales of its core product [7]. - Huahong Technology predicts a net profit increase of 3047.48% to 3721.94%, with expected profits between 70 million and 85 million yuan, benefiting from rising rare earth product prices [8]. - Huaxia Airlines expects a net profit increase of 741.26% to 1008.93%, with profits projected between 220 million and 290 million yuan, due to improved demand for air travel [9]. - Xianfeng Holdings anticipates a net profit increase of 524.58% to 671.53%, with expected profits between 34 million and 42 million yuan, largely due to non-recurring gains [10]. - Xinyisheng expects a net profit increase of 327.68% to 385.47%, with profits projected between 370 million and 420 million yuan, driven by growth in AI-related investments [12]. - Hengsheng Electronics forecasts a net profit increase of approximately 740.95%, with expected profits around 251 million yuan, aided by significant non-recurring gains [13]. - CICC anticipates a net profit increase of 55% to 78%, with expected profits between 3.453 billion and 3.966 billion yuan, driven by growth in investment banking and wealth management [14]. - Xinda Securities expects a net profit increase of 50% to 70%, with profits projected between 921 million and 1.044 billion yuan, supported by improved asset management [15]. - Shanxi Securities forecasts a net profit increase of 58.17% to 70.72%, with expected profits between 504 million and 544 million yuan, driven by growth in wealth management and international business [16]. - Guocheng Mining anticipates a net profit increase of 1046.75% to 1174.69%, with expected profits between 493 million and 548 million yuan, primarily due to non-recurring gains from asset sales [17]. - China Rare Earth expects a net profit of 136 million to 176 million yuan, recovering from a loss of 244 million yuan in the previous year, aided by improved market conditions [18]. - Perfect World anticipates a net profit of 480 million to 520 million yuan, recovering from a loss of 177 million yuan, driven by successful game launches and esports growth [19]. - Huanghe Xuanfeng expects a net loss of 285 million yuan, impacted by intense competition and weak demand in the superhard materials sector [20][21]. - JA Solar forecasts a net loss of 2.5 billion to 3 billion yuan, worsening from a loss of 874 million yuan, due to industry-wide supply-demand imbalances [22]. - Shanxi Black Cat anticipates a net loss of 490 million to 540 million yuan, driven by declining sales and prices of its main products [23]. - Xinda Real Estate expects a net loss of 3.5 billion to 3.9 billion yuan, transitioning from profit to loss due to reduced project deliveries and impairment provisions [24]. Major Contracts - Zhongchen Co. won a project from Southern Power Grid worth 379 million yuan, representing 12.26% of its audited revenue for 2024 [26]. - Gaode Infrared signed a procurement agreement for a complete equipment system worth 879 million yuan, accounting for 32.84% of its 2024 audited revenue, expected to positively impact this year's performance [27].
特一药业(002728) - 2025 Q2 - 季度业绩预告
2025-07-14 08:10
证券代码:002728 证券简称:特一药业 公告编号:2025-046 特一药业集团股份有限公司 2025 年半年度业绩预告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、 误导性陈述或重大遗漏。 一、本期业绩预计情况 1、业绩预告期间:2025 年 1 月 1 日至 2025 年 6 月 30 日 1、营销组织变革奠定基础:公司营销组织架构组建完成,自营团队已形成初步规 模并高效运转,为营销工作的持续深化奠定了坚实基础。 2、核心产品销售稳步恢复:本报告期,公司核心产品"特一"牌止咳宝片的销量 实现 3.31 亿片,恢复至 2023 年同期的 61.29%。其中,线上业务发展迅速,成功拓展了 新的消费群体。 2、业绩预告情况:扭亏为盈 同向上升 同向下降 3、品牌建设投入强化长期动能:公司持续强化品牌建设,报告期投入达到 1.65 亿 元。虽然该项投入增加了当期费用,但显著提升了"特一"品牌知名度,特别是在线上 受众群体中的影响力,有力支撑了公司"1+N"产品战略的长期发展。 | 项目 | 本报告期 | | | 上年同期 | | | --- | --- | --- | --- | ...
特一药业(002728) - 关于提前归还2023年度以简易程序向特定对象发行股票暂时补充流动资金的募集资金的公告
2025-07-02 08:00
关于提前归还 2023 年度以简易程序向特定对象发行股票 暂时补充流动资金的募集资金的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假记载、 误导性陈述或重大遗漏。 股票代码:002728 股票简称:特一药业 公告编号:2025-045 2025 年 7 月 3 日 特一药业集团股份有限公司 特一药业集团股份有限公司(以下简称"公司")于 2024 年 12 月 26 日召开第五 届董事会第二十七次会议,审议通过了《关于使用 2023 年度以简易程序向特定对象发 行股票部分闲置募集资金暂时补充流动资金的议案》,为了有效提高募集资金的使用效 率,减少财务费用,降低运营成本,维护公司和股东利益,在确保公司 2023 年度以简 易程序向特定对象发行股票募集资金投资项目按进度实施的前提下,同意公司使用不超 过人民币 2 亿元以简易程序向特定对象发行股票闲置募集资金暂时补充流动资金,董事 会审议通过后,自首次办理暂时补充流动资金之日起,不超过 12 个月,到期后归还至 募集资金专用账户。具体内容详见公司于 2024 年 12 月 27 日刊登于巨潮资讯网 (http://www.cninfo.c ...
特一药业(002728) - 特一药业集团股份有限公司章程
2025-06-30 10:46
特一药业集团股份有限公司 章 程 二〇二五年七月 特一药业集团股份有限公司 章程 目 录 第一章 总则 第二章 经营宗旨和范围 第三章 股份 第一节 股份发行 第二节 股份增减和回购 第三节 股份转让 第四章 股东和股东会 第一节 股东的一般规定 第二节 控股股东和实际控制人 第三节 股东会的一般规定 第四节 股东会的召集 第五节 股东会的提案与通知 第六节 股东会的召开 第七节 股东会的表决和决议 第五章 董事和董事会 第一节 董事的一般规定 第二节 董事会 第三节 独立董事 第四节 董事会专门委员会 第六章 高级管理人员 第七章 财务会计制度、利润分配和审计 第一节 财务会计制度 第二节 内部审计 第三节 会计师事务所的聘任 第八章 通知和公告 第一节 通知 第二节 公告 第九章 合并、分立、增资、减资、解散和清算 第一节 合并、分立、增资和减资 第二节 解散和清算 第十章 修改章程 第十一章 附则 特一药业集团股份有限公司 章程 第一章 总则 第一条 为维护公司、股东、职工和债权人的合法权益,规范公司的组织和行为, 根据《中华人民共和国公司法》(以下简称《公司法》)、《中华人民共和国证券法》 (以下简称 ...
特一药业(002728) - 董事、高级管理人员薪酬管理制度
2025-06-30 10:46
特一药业集团股份有限公司 董事、高级管理人员薪酬管理制度 第一章 总则 第一条 为规范特一药业集团股份有限公司(以下简称"公司")董事、高级管理 人员的薪酬管理,建立科学有效的激励和约束机制,有效调动董事、高级管理人员的积 极性,确保公司发展战略目标的实现,根据《中华人民共和国公司法》《中华人民共和 国证券法》《上市公司治理准则》等有关法律法规、规范性文件以及《特一药业集团股 份有限公司章程》(以下简称《公司章程》)的有关规定,结合公司实际情况,制定本 制度。 第二条 本制度适用于《公司章程》规定的董事、高级管理人员。 第三条 公司薪酬制度遵循以下原则: (一)体现收入水平符合公司规模与业绩的原则,同时与外部薪酬水平相符; (二)体现责、权、利对等的原则,薪酬与岗位价值高低、承担责任大小相符; (三)体现公司长远利益的原则,与公司持续健康发展的目标相符; (四)体现激励与约束并重、奖罚对等的原则,薪酬发放与考核挂钩、与奖惩挂钩。 第二章 管理机构 第四条 公司董事会薪酬与考核委员会在董事会的授权下负责拟定董事、高级管理 人员的薪酬标准和方案;负责审查董事、高级管理人员履行职责情况并对其进行年度考 核;负责对公 ...
特一药业(002728) - 内部控制制度
2025-06-30 10:46
特一药业集团股份有限公司 内部控制制度 第一章 总则 第一条 为了加强和规范特一药业集团股份有限公司(以下简称"公司")内部控制, 促进公司规范运作和健康发展,提高公司风险管理水平,保护投资者合法权益,根据《中 华人民共和国公司法》《中华人民共和国证券法》《企业内部控制基本规范》及其配套指 引、《深圳证券交易所股票上市规则》《深圳证券交易所上市公司自律监管指引第1号—— 主板上市公司规范运作》等有关法律法规、规范性文件以及《特一药业集团股份有限公司 章程》(以下简称《公司章程》)的有关规定,结合公司实际情况,制定本制度。 第二条 本制度所称内部控制,是指由公司董事会、审计委员会、高级管理人员和全 体员工实施的、旨在实现控制目标的过程。 内部控制的目标是合理保证公司经营管理合法合规、资产安全、财务报告及相关信息 真实完整,提高经营效率和效果,促进公司实现发展战略。 第三条 公司建立与实施内部控制,应当遵循下列原则: (一)全面性原则。内部控制应当贯穿决策、执行和监督全过程,覆盖公司及其所属 子公司的各种业务和事项。 (二)重要性原则。内部控制应当在全面控制的基础上,关注重要业务事项和高风险 领域。 (三)制衡性 ...
特一药业(002728) - 对外投资管理制度
2025-06-30 10:46
特一药业集团股份有限公司 对外投资管理制度 第一章 总则 第一条 为了加强特一药业集团股份有限公司(以下简称"公司")对外投资管理, 规范对外投资行为,提高公司资产的经营效益,切实保护公司和投资者的利益,根据《中 华人民共和国公司法》(以下简称《公司法》)、《中华人民共和国证券法》《深圳证 券交易所股票上市规则》(以下简称《股票上市规则》)、《深圳证券交易所上市公司 自律监管指引第1号——主板上市公司规范运作》等有关法律法规、规范性文件以及《特 一药业集团股份有限公司章程》(以下简称《公司章程》)的有关规定,结合公司实际 情况,制定本制度。 第二条 本制度所称的对外投资是指公司为获取未来收益而将一定数量的货币资 金、股权,以及经评估后的实物或无形资产作价出资,对外进行各种形式的投资活动。 第三条 按照投资期限的长短,公司对外投资分为短期投资和长期投资。 (一)短期投资主要指:公司购入的能随时变现且持有时间不超过一年(含一年) 的投资,包括各种股票、债券、基金等; (二)长期投资主要指:公司超过一年不能随时变现或不准备变现的各种投资,包 括债券投资、股权投资和其他投资等。 第四条 本制度适用于公司及下属各子公司 ...
特一药业(002728) - 董事会提名委员会工作细则
2025-06-30 10:46
特一药业集团股份有限公司 董事会提名委员会工作细则 第一章 总则 第一条 为规范特一药业集团股份有限公司(以下简称"公司")董事及高级管理 人员的选聘,优化董事会组成,完善公司治理结构,根据《中华人民共和国公司法》《上 市公司治理准则》等有关法律法规、规范性文件以及《特一药业集团股份有限公司章程》 (以下简称《公司章程》)的有关规定,结合公司实际情况,公司特设立董事会提名委 员会,并制订本工作细则。 第二条 董事会提名委员会是董事会依据相应法律法规设立的专门工作机构,对董 事会负责并报告工作,主要负责拟定董事、高级管理人员的选择标准和程序,对董事、 高级管理人员人选及其任职资格进行遴选、审核,并向董事会提出建议。 第三条 公司董事会办公室负责提名委员会的工作联络、会议组织、材料准备和档 案管理等日常工作。 第二章 人员组成 第四条 提名委员会成员由三名董事组成,其中独立董事两名,并由独立董事担任 召集人。 第五条 提名委员会委员由董事长、二分之一以上的独立董事或者三分之一以上的 全体董事提名,并由董事会选举产生。 提名委员会设主任委员(召集人)一名,由独立董事担任,经董事会批准产生,负 责主持委员会工作。 第 ...